Help us maintain the quality of our job listings. If you find any issues with this job post, please let us know.
Select the reason you're reporting this job:
To those who say “impossible, impractical, unrealistic,” we say: “CHALLENGE ACCEPTED.”
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring RNAi-based medicines to market.
We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases.
Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today’s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate.
Alnylam is turning scientific possibility into reality - in 2018, the FDA and EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. We now have four additional medicines on the market. Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development.
We are a global and diverse company of 1,900+ people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we've been named a Science Magazine Top Employer 3 years in a row ('19-'21), a Boston Globe Top Place to Work 8x in a row ('15-'21) and Fast Company's #1 Best Workplace for Innovators ('22
We are based in Cambridge, U.S., with offices throughout Europe, Asia, and South America.
We invite you to connect with us by following us on LinkedIn, Facebook (@AlnylamPharma) Twitter (@Alnylam), Instagram (@AlnylamPharma) and YouTube.
See our community guidelines: https://bit.ly/2FcRhJy.
Present a positive image of the company and develop awareness of Alnylam’s RNAi platform with relevant groups of healthcare professionals
Develop, own, and drive territory and account plans, including customer targeting and cycle plan, in line with Marketing strategy and Business Operations guidance
Achieve pre-launch and post-launch KPIs, including sales and volume targets
Use advanced sales skills to ensure consistent and continuous messaging
Perform detailed analysis of the assigned territory to identify, assess, and develop relevant centers for diagnosis and treatment
Drive patient group identification, diagnosis and referral rates by strategic intersectoral referral network management in close cooperation with other field based functions
Develop trusted relationships with a portfolio of customers to ensure market penetration, after developing a thorough understanding of key customer needs and requirements
Ensure the correct products and services are delivered to customers in a timely manner by collaborating with internal stakeholders (commercial, supply chain, and compliance) and external centers
Establish and maintain contact with key customers and provide commercial and scientific services to ensure access at site of care, and that logistics are in place to administer product
Manage and execute local meetings to drive diagnosis and treatment rates, in collaboration with the Medical Affairs Team for physicians and other healthcare professionals
Represent Alnylam at local and national events and congresses
Serve as the link of communication between key customers and internal teams
Liaise and collaborate with relevant internal staff (Medical Affairs, Sales Director, Marketing, Market Access and Business Operations), as required
Steer regular local aligment meetings with other field based functions to ensure proper implemnation and outcomes against the committet territory and account plans.
Timely and accurate reporting and continuous diligent maintenance of the CRM database
Conduct all activities to highest ethical standards in accordance with country code of practice and local Laws and regulations
Significant domestic travel and occasional international travel as needed
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
Required profile
Experience
Industry :
Biotech: Biology + Technology
Spoken language(s):
English
Check out the description to know which languages are mandatory.